Monaco Asset Management SAM »

Taysha Gene Therapies shares owned by Monaco Asset Management SAM

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Monaco Asset Management SAM from 13F filings

Historical chart of Monaco Asset Management SAM investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Monaco Asset Management SAM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Monaco Asset Management SAM

Quarter filed Position value Share count Share price at filing
2023-12-31 $522k 295k 1.77

More positions owned by Monaco Asset Management SAM

Ferrari Nv Ord Put Option (RACE)
Alcoa (AA)
Apple Put Option (AAPL)
Agnico (AEM)
Viatris (VTRS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Zoom Video Communications In Cl A (ZM)
Newmont Mining Corporation (NEM)
Pan American Silver Corp Can (PAAS)
Paypal Holdings (PYPL)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Fate Therapeutics (FATE)
Palo Alto Networks Put Option (PANW)
NVIDIA Corporation Put Option (NVDA)
Etf Managers Tr Prime Junir Slvr

View all positions for Monaco Asset Management SAM

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
T. Rowe Price Associates
Schonfeld Strategic Advisors
Exome Asset Management
Alphabet
Quantum Private Wealth
Palo Alto Investors

View all funds holding Taysha Gene Therapies